Wednesday, February 12th 2020
Didier Betbeder, CEO & CSO of Vaxinano, explains how innovative and efficient is its vaccine platform.
...Read more
Thursday, January 16th 2020
Didier Betbeder, CEO & CSO of Vaxinano, presents the vaccine platform to Vaccinology Club of the French Society for Immunology
...Read more
Thursday, December 05th 2019
Didier Betbeder, CEO & CSO of Vaxinano, presents for the first time the preclinical results of the anti-toxoplasma vaccine, including non-human primates.
...Read more
Monday, July 01st 2019
Vaxinano Announces the Signing of a Third Research and Development Program with a Leader in the Vaccine Industry.
...Read more
Thursday, June 06th 2019
Faced with the worldwide emergence of antibiotic resistance, Vaxinano obtains funding for research with Immunova Analises Biologicas and Lesaffre International to develop a vaccine against avian colibacillosis.
...Read more
27/03/2019
Visit the website
Wednesday, January 16th 2019
A new pharmaceutical industrial leader trusts Vaxinano for the development of veterinary vaccines.
...Read more
Tuesday, December 11st 2018
This December 11 was held the award ceremony of the 2018 Innovation competition where Vaxinano was rewarded in the field of Health.
...Read more
Monday, September 10th 2018
Vaxinano has signed a research contract with a third industrial partner to develop a new veterinary vaccine.
...Read more
Saturday, September 01st 2018
The first industrial partner of Vaxinano, a world leader in the animal pharmaceutical industry, has renewed their contract and underlined their confidence in the company.
...Read more
Friday, May 04th 2018
Vaxinano has begun GMP-compliant pharmaceutical production in its vaccine platform
...Read more